We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The Centers for Medicare & Medicaid Services (CMS) is using a proposed rule issued today to test the legal waters for its plan to collect and share prescription drug plan data to base Medicare reimbursement on product comparisons, sources say.
Sen. Chuck Grassley (R-Iowa) is calling on the Centers for Medicare & Medicaid Services (CMS) to clarify its new policy on compounded inhalation drugs, following the agency’s earlier decision to change how it reimburses for the products.
A group of federal agencies is joining forces with the drug industry to form a public-private partnership to search for new biomarkers in an effort to speed drug development and lower costs.
The FDA does not do a good enough job in making drug development information available to the public, and proposals for clinical-trial registries do not go far enough to address this problem, the activist group Public Citizen said in a study published in the Duke Law Journal.
A bipartisan group of lawmakers is pressuring Senate leadership to vote on legislation establishing a federal importation protocol, citing recent regulatory and legislative changes as necessitating the change.
As part of a federal effort to implement comparative trials, Senate Majority Leader Bill Frist (R-Tenn.) plans to use a recent Congressional Budget Office (CBO) report on drug industry R&D to get additional federal funding for these programs, a congressional source says.
A bipartisan group of lawmakers is pressuring Senate leadership to vote on legislation establishing a federal importation protocol, citing recent regulatory and legislative changes as necessitating the change.
The pharmaceutical industry is wasting more than $50 billion each year through inadequate IT and misplaced decisionmaking, according to an academic study.
Pfizer is joining the ranks of vaccine manufacturers, with the purchase of a company developing technology that boosts the immune system by shooting microscopic DNA-coated gold particles into the skin.